Integrum
9
1
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Magnetic Bead Tracking System and eOPRA Implant System With Bionic Prosthesis for Transtibial Amputees
Role: collaborator
A Multicenter, Multinational, Cohort Long-term Post-market Clinical Follow-up (PMCF) of the Safety and Efficacy of the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System When Used for Transhumeral Implantation in Amputee Patients
Role: lead
Neuromusculoskeletal Interface for Bionic Arms
Role: collaborator
e-OPRA Implant System for Lower Limb Amputees
Role: lead
Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP
Role: lead
Osseointegrated Human-Machine Gateway
Role: lead
Osseointegrated Transtibial Prosthesis With Neural Interface
Role: collaborator
Osseointegrated Prostheses for the Rehabilitation of Amputees
Role: lead
Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain
Role: lead
All 9 trials loaded